Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester is a synthetic small molecule belonging to the class of organic compounds known as 2-naphthalene sulfonic acids and derivatives. It is an experimental compound, not approved for clinical use, and has been primarily studied in biochemical and structural biology contexts. The compound features a naphthalenesulfonamide moiety linked to an amidinophenylanine residue and a piperidine carboxylic acid methyl ester group. Its mechanism of action is not well characterized in the literature, but structurally related compounds are often investigated as protease inhibitors or enzyme modulators[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester.